The Journal of Immunology, Vol 143, Issue 5 1580-1583, Copyright © 1989 by American Association of Immunologists

ARTICLES

FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein, cyclophilin

JJ Siekierka, MJ Staruch, SH Hung and NH Sigal
Merck, Sharp, and Dohme Research Laboratories, Department of Immunology Research, Rahway, NJ 07065.

A novel macrolide antibiotic, FK-506, isolated from Streptomyces tsukubaensis, has been shown to be a potent immunosuppressive agent in vivo and in vitro. FK-506 shares a number of immunosuppressive properties with the cyclic peptide, cyclosporin A (CsA), although 10 to 100 times more potent in this regard. These similarities suggest that both agents may share a similar mechanism(s) of action at the biochemical level. We have identified a cytoplasmic binding protein for FK-506 in the human T cell line, JURKAT, using [3H]FK-506. The FK-506 binding protein has a mr of 10 to 12 kDa (as determined by gel filtration), is heat stable and does not bind CsA. This contrasts with the CsA binding protein, cyclophilin, in that cyclophilin is heat labile and has a mr of 15 to 17 kDa. Our data suggest that FK-506 binds to a low m.w. protein(s) in JURKAT cells, which is distinct from cyclophilin. This protein may mediate the immunosuppressive effects of FK-506 in T cells. In addition, our results suggest that the immunosuppressive activity of FK-506, as with CsA, is mediated by an intracellular mechanism.

This article has been cited by other articles:

				M. Fukudo, I. Yano, S. Masuda, M. Okuda, and K.-i. Inui Distinct Inhibitory Effects of Tacrolimus and Cyclosporin A on Calcineurin Phosphatase Activity J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 816 - 825. [Abstract] [Full Text] [PDF]

				M. Furutani, T. Iida, S. Yamano, K. Kamino, and T. Maruyama Biochemical and Genetic Characterization of an FK506-Sensitive Peptidyl Prolyl cis-trans Isomerase from a Thermophilic Archaeon, Methanococcus thermolithotrophicus J. Bacteriol., January 15, 1998; 180(2): 388 - 394. [Abstract] [Full Text]

				F. A. Antoni, R. J. O. Barnard, M. J. Shipston, S. M. Smith, J. Simpson, and J. M. Paterson Calcineurin Feedback Inhibition of Agonist-evoked cAMP Formation J. Biol. Chem., November 24, 1995; 270(47): 28055 - 28061. [Abstract] [Full Text] [PDF]

				T. Smith, L. R. Ferreira, C. Hebert, K. Norris, and J. J. Sauk Hsp47 and Cyclophilin B Traverse the Endoplasmic Reticulum with Procollagen into Pre-Golgi Intermediate Vesicles J. Biol. Chem., August 4, 1995; 270(31): 18323 - 18328. [Abstract] [Full Text] [PDF]

				B Hendey, C. Klee, and F. Maxfield Inhibition of neutrophil chemokinesis on vitronectin by inhibitors of calcineurin Science, October 9, 1992; 258(5080): 296 - 299. [Abstract] [PDF]

				S. Schreiber Chemistry and biology of the immunophilins and their immunosuppressive ligands Science, January 18, 1991; 251(4991): 283 - 287. [Abstract] [PDF]

				B. Bierer, P. Somers, T. Wandless, S. Burakoff, and S. Schreiber Probing immunosuppressant action with a nonnatural immunophilin ligand Science, October 26, 1990; 250(4980): 556 - 559. [Abstract] [PDF]